Risk factors for human T-cell lymphotropic virus types I and II (HTLV-I and -II) in blood donors: The retrovirus epidemiology donor study

Journal of Acquired Immune Deficiency Syndromes and Human Retrovirology

Volumn 14, Issue 3, 1997, Pages 263-271

  Schreiber, G B ^a   Murphy, E L ^b   Horton, J A ^a   Wright, D J ^a   Garfein, R ^a   Co Chien, H ^a   Nass, C C ^c  

^a WESTAT   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

^c AMERICAN RED CROSS BLOOD SERVICES   (United States)

Author keywords

Blood donors; Epidemiology; HTLV I; HTLV II; Injection drug use; Risk factors; Sexual transmission; Transfusion

Indexed keywords

ACADEMIC ACHIEVEMENT; ADULT; ARTICLE; BLOOD DONOR; CONTROLLED STUDY; FEMALE; HUMAN; HUMAN T CELL LEUKEMIA VIRUS 1; HUMAN T CELL LEUKEMIA VIRUS 2; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RETROVIRUS INFECTION; RISK FACTOR; SCREENING; SEXUALLY TRANSMITTED DISEASE; VIRUS TRANSMISSION;

HTLV; HTLV II; HUMAN IMMUNODEFICIENCY VIRUS; HUMAN T-LYMPHOTROPIC VIRUS 1; HUMAN T-LYMPHOTROPIC VIRUS 2; UNIDENTIFIED RETROVIRUS;

EID: 0031001935     PISSN: 10779450     EISSN: None     Source Type: Journal    
DOI: 10.1097/00042560-199703010-00011     Document Type: Article

References (52)

1. Poiesz BJ, Ruscetti FW, Gazdar AF, Bunn PA, Minna JD, Gallo RC. Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma. Proc Natl Acad Sci USA 1980;77:7415-9.
2. Kalyanaraman VS, Sarngadharan MG, Robert-Guroff M, Miyoshi I, Golde D, Gallo RC. A new subtype of human T-cell leukemia virus (HTLV-II) associated with a T-cell variant of hairy cell leukemia. Science 1982;218:571-3.
3. Uchiyama T, Yodoi J, Sagawa K, Takatsuki K, Uchino, H. Adult T-cell leukemia: clinical and hematologic features of 16 cases. Blood 1977;50:481-92.
4. Gessain A, Barin F, Vernant JC, et al. Antibodies to human T-lymphotropic virus type-I in patients with tropical spastic paraparesis. Lancet 1985;2:407-10.
5. Hinuma Y, Komoda H, Chosa T, et al. Antibodies to adult T-cell leukemia-virus-associated antigen (ATLA) in sera from patients with ATL and controls in Japan: a nationwide seroepidemiologic study. Int J Cancer 1982;29:631-5.
6. Blattner WA, Blayney DW, Robert-Guroff M, et al. Epidemiology of human T-cell leukemia/lymphoma virus. J Infect Dis 1983;147:406-16.
7. Blattner WA, Kalyanaraman VS, Robert-Guroff M, et al. The human type-C retrovirus, HTLV, in Blacks from the Caribbean region, and the relationship to adult T-cell leukemia/lymphoma. Int J Cancer 1982;30:257-64.
8. Saxinger W, Blattner WA, Levine PH, et al. Human T-cell leukemia virus (HTLV-I) antibodies in Africa. Science 1984;225:1473-6.
9. de-Thé G, Giordano C, Gessain A, et al. Human retroviruses, HTLV-I, HIV-I and HIV-2 and neurological diseases in some equitorial areas of Africa. J Acquir Immune Defic Syndr 1989;2:550-6.
10. de Thé G, Gout O, Gessain A, Lyon-Caen O. HTLV-I associated myelopathies in Western Europe and tropical Africa: clinical, epidemiological and immunoverological observations. In: Blattner WA, ed. Human retrovirology: HTLV. New York: Raven Press, 1990;333-47.
11. Reeves WC, Saxinger C, Brenes MM, et al. Human T-cell lymphotropic virus type I (HTLV-I) seroepidemiology and risk factors in metropolitan Panama. Am J Epidemiol 1988;127:532-9.
12. Maloney EM, Ramirez H, Levin A, Blattner WA. A survey of the human T-cell lymphotropic virus type I (HTLV-I) in southwestern Colombia. Int J Cancer 1989;44:419-23.
13. Williams AE, Fang CT, Slamon DJ, et al. Seroprevalence and epidemiologic correlates of HTLV-I infection in US blood donors. Science 1988;240:643-6.
14. Lee HH, Swanson P, Rosenblatt JD, et al. Relative prevalence and risk factors of HTLV-I and HTLV-II infection in US blood donors. Lancet 1991;337:1435-9.
15. Okochi K, Sato H, Hinuma Y. A retrospective study on transmission of adult T-cell leukemia virus by blood transfusion: seroconversion in recipient. Vox Sang 1984;46:245-53.
16. Robert-Guroff M, Weiss SH, Giron JA, et al. Prevalence of antibodies to HTLV-I, -II, and -III in intravenous drug abusers from an AIDS endemic region. JAMA 1986;255:3133-7.
17. Kajiyama W, Kashiwagi S, Ikematsu H, Hayashi J, Nomura H, Okochi K. Intrafamilial transmission of adult T-cell leukemia virus. J Infect Dis 1986;154:851-7.
18. Murphy EL, Figueroa JP, Gibbs WN, et al. Sexual transmission of human T-lymphotropic virus type I (HTLV-I). Ann Intern Med 1989;111:555-60.
19. Hino S, Yamaguchi K, Katamine S, et al. Mother-to-child transmission of human T-cell leukemia virus type I. Jpn J Cancer Res 1985;76:474-80.
20. Saxon A, Stevens RH, Golde DW. T-lymphocyte variant of hairy cell leukemia. Ann Intern Med 1978;888:323-6.
21. Rosenblatt JD, Golde DW, Wachsman W, et al. A second isolate of HTLV-II associated with atypical hairy-cell leukemia. N Engl J Med 1986;315:372-7.
22. Hjelle B, Appenzeller O, Mills R, et al. Chronic neurodegenerative disease associated with HTLV-II infection. Lancet 1992;339:645-6.
23. Murphy EL, Friday J, Smith JW, et al. High prevalence of HTLV-associated myelopathy (HAM) among subjects infected with HTLV-I and HTLV-II [Abstract]. Transfusion 1993;33(95):685.
24. Lee H, Swanson P, Shorty VS, Zack JA, Resenblatt JD, Chen IS. High rate of HTLV-II infection in seropositive IV drug abusers in New Orleans. Science 1989;244:471-5.
25. Ehrlich GD, Glaser JB, LaVigne K, et al. Prevalence of human T-cell leukemia/lymphoma virus (HTLV) type II infection among high-risk individuals: type-specific identification of HTLVs by polymerase chain reaction. Blood 1989;74:1658-64.
26. Khabbaz RF, Onorato IM, Cannon RO, Hartley TM, Roberts B, Hosein B, Kaplan JE. Seroprevalence of HTLV-I and HTLV-II among intravenous drug users and persons in clinics for sexually transmitted diseases. N Engl J Med 1992; 326:375-80.
27. Reeves WC, Cutler JR, Gracis F, et al. Human T cell lymphotropic virus infection in Guaymi Indians from Panama. Am J Trop Med Hyg 1990;43:410-8.
28. Levine PH, Jacoboson S, Elliott R, et al. HTLV-II infection in Florida Indians. AIDS Res Hum Retroviruses 1993;9:123-7.
29. Hjelle B, Scalf R, Swenson S. High frequency of human T-cell leukemia-lymphoma virus type II infection in New Mexico blood donors: determination by sequence-specific oligonucleotide hybridization. Blood 1990;76:450-4.
30. Zaninovic V, Sanzon F, Lopez F, et al. Geographic independence of HTLV-I and HTLV-II foci in the Andes highland, the Atlantic coast, and the Orinoco of Colombia. AIDS Res Hum Retroviruses 1994;10:97-101.
31. Sullivan MT, Williams AE, Fang CT, Grandinetti T, Bernard J, Poiez BJ, Ehrlich GD. Transmission of human T-lymphotropic virus types I and II by blood transfusion: a retrospective study of recipients of blood components (1983 through 1988). Arch Intern Med 1991;151:2043-8.
32. Donegan E, Lee H, Operskalski EA, et al. Transfusion transmission of retroviruses: human T-lymphotropic virus types I and II compared with human immunodeficiency virus type I. Transfusion 1994;34:478-83.
33. Rios M, Khabbaz RF, Kaplan JE, Hall WW, Kessler D, Bianco C. Transmission of human T-cell lymphotropic virus (HTLV) type II by transfusion of HTLV-I screened blood products. J Infect Dis 1994;170:206-10.
34. Hjelle B, Cyrus S, Swenson SG. Evidence for sexual transmission of human T-lymphotropic virus type II. Ann Intern Med 1992;116:90-1.
35. Feigenbaum F, Fang CT, Sandler SG. Human T-lymphotropic virus type II in Panamanian Guaymi Indians. Transfusion 1994;34:158-161.
36. Sullivan MT, Williams AE, Fang CT, Notari EP, Poiesz BJ, Ehrlich GD and the American Red Cross HTLV-I/II Collaborative Study Group. Human T-lymphotropic virus (HTLV) types I and II infection in sexual contacts and family members of blood donors who are seropositive for HTLV type I or II. Transfusion 1993;33:585-90.
37. Eble BE, Busch M, Guiltinan AM, Khayam-Bashi H, Murphy EL. Determination of human T lymphotropic virus type by polymerase chain reaction and correlation with risk factors in northern California blood donors. J Infect Dis 1993;167:954-7.
38. Heneine W, Woods T, Green D, et al. Detection of HTLV-II in breastmilk of HTLV-II infected mothers. Lancet 1992;340:1157-8.
39. Hosmer DW, Lemeshow S. Applied logistic regression. New York: John Wiley and Sons, 1989: 187-215.
40. Mantel N, Haenszel W. Statistical aspects of the analysis of data from retrospective studies of disease. J Natl Cancer Inst 1959;22:719-48.
41. SAS/STAT user's guide, version 6, 4th ed. Cary, NC: SAS Institute Inc, 1989.
42. Ibrahim NA, Mobley MF. Recruitment and retention of blood donors: a strategic linkage approach. Health Care Manage Rev 1993;18:67-73.
43. Lightman E. Continuity in social policy behaviors: the case for voluntary blood donorship. J Soc Policy 1982;10:53-70.
44. Piliavin J, Callero P. Giving blood: the development of an altruistic identity. Baltimore: The Johns Hopkins University Press, 1991.
45. Murphy EL, Figueroa JP, Gibbs WN, et al. Human T-lymphotropic virus type I (HTLV-I) seroprevalence in Jamaica. Am J Epidemiol 1991;133:1114-24.
46. Murphy EI, Bryzman S, Williams AE, et al. Demographic determinants of hepatitis C virus (HCV) seroprevalence in United States blood donors. JAMA 1996;275:995-1000.
47. Korelitz JJ, Williams AE, Busch MP, Zuck TF, Ownby HE, Matijas LJ, Wright, DJ. Demographic characteristics and prevalence of serologic markers among donors who use the confidential unit exclusion process: the Retrovirus Epidemiology Donor Study. Transfusion 1994;34:870-6.
48. Figueroa JP, Morris J, Brathwaite EW, et al. Risk factors for HTLV-I among heterosexual STD clinic attenders. J Acquir Immune Defic Syndr Human Retrovirol 1995;9:81-8.
49. Stuver SO, Tachibana N, Okayama A, et al. Heterosexual transmission of human T cell leukemia/lymphoma virus type I among married couples in southwestern Japan: an initial report from the Miyazaki Cohort Study. J Infect Dis 1993;167:57-66.
50. Vlahov D, Khabbaz RF, Cohn S, Galai N, Taylor E, Kaplan JE. Incidence and risk factors for human T-lymphotropic virus type II seroconversion among injecting drug users in Baltimore, MD, USA. J Acquir Immune Defic Syndr Human Retrovirol 1995;9:89-96.
51. Goubau P, Carton H, Cornet P, et al. Human T-cell lymphotropic virus type I infection and tropical spastic paraparesis in Belgian expatriates. J Med Virol 1992;36:13-5.
52. Fujino T, Fujiyoshi T, Yashiki S, Sonoda S, Otsuka H, Nagata Y. HTLV-I transmission from mother to fetus via placenta. Lancet 1992;340:1157.